Online citations, reference lists, and bibliographies.
← Back to Search

Clinical Uncertainties, Health Service Challenges, And Ethical Complexities Of HIV "test-and-treat": A Systematic Review.

Sonali P. Kulkarni, K. R. Shah, K. Sarma, A. Mahajan
Published 2013 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Despite the HIV "test-and-treat" strategy's promise, questions about its clinical rationale, operational feasibility, and ethical appropriateness have led to vigorous debate in the global HIV community. We performed a systematic review of the literature published between January 2009 and May 2012 using PubMed, SCOPUS, Global Health, Web of Science, BIOSIS, Cochrane CENTRAL, EBSCO Africa-Wide Information, and EBSCO CINAHL Plus databases to summarize clinical uncertainties, health service challenges, and ethical complexities that may affect the test-and-treat strategy's success. A thoughtful approach to research and implementation to address clinical and health service questions and meaningful community engagement regarding ethical complexities may bring us closer to safe, feasible, and effective test-and-treat implementation.
This paper references
10.1016/S0140-6736(08)61697-9
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
R. Granich (2009)
10.1056/NEJMe1107487
Antiretroviral treatment as prevention.
S. Hammer (2011)
10.1038/4631006A
'Seek, test and treat' slows HIV
E. Hayden (2010)
10.1097/COH.0b013e32834788e7
HIV-1 treatment as prevention: the good, the bad, and the challenges
Kumi Smith (2011)
10.1371/journal.pone.0029098
A Mathematical Model of Comprehensive Test-and-Treat Services and HIV Incidence among Men Who Have Sex with Men in the United States
S. Sorensen (2012)
10.2217/HIV.09.35
Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges.
C. Wester (2009)
10.1111/j.1365-2796.2011.02456.x
HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance
B. Nichols (2011)
10.1097/01.aids.0000390705.73759.2c
Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission
J. Weber (2010)
10.1086/651480
Developing and evaluating comprehensive HIV infection control strategies: issues and challenges.
V. DeGruttola (2010)
10.7326/0003-4819-154-11-201106070-00345
Thirty Years of HIV and AIDS: Future Challenges and Opportunities
C. Dieffenbach (2011)
10.2105/AJPH.2010.300050
Preserving human rights in the era of "test and treat" for HIV prevention.
J. Fu (2011)
10.1089/apc.2010.0086
From access to engagement: measuring retention in outpatient HIV clinical care.
M. Mugavero (2010)
10.1097/QAD.0b013e3283408735
The role of the health system in HIV treatment-as-prevention.
T. Bärnighausen (2010)
10.1111/J.1467-9566.2010.01297.X
HIV Treatment and Prevention in International Perspective
H. McMullen (2010)
10.2174/157016211798038588
Articulating A Rights-Based Approach to HIV Treatment and Prevention Interventions
D. Barr (2011)
10.7326/0003-4819-156-4-201202210-00383
Antiretroviral Medication and HIV Prevention: New Steps Forward and New Questions
K. Mayer (2012)
10.1007/s10464-012-9522-x
The Quality Implementation Framework: A Synthesis of Critical Steps in the Implementation Process
D. Meyers (2012)
10.1089/aid.2009.0267
Can we treat our way out of HIV?
Rowena Johnston (2010)
10.1097/QCO.0b013e3283422c8c
‘Test-and-treat’: the end of the HIV epidemic?
V. Cambiano (2011)
10.1080/15265161.2011.613524
Treatment-as-Prevention Needs to Be Considered in the Just Allocation of HIV Drugs
B. Haire (2011)
10.1080/09540120802068753
Beyond buzzwords: toward a community-based model of the integration of HIV treatment and prevention
E. Mykhalovskiy (2009)
10.1016/S0140-6736(11)61116-1
HPTN 052 and the future of HIV treatment and prevention
W. Cates (2011)
10.1126/science.328.5981.976
Honing the test-and-treat HIV strategy.
T. Mastro (2010)
10.1016/S1473-3099(11)70037-8
HIV-2 down, HIV-1 to go? Understanding the possibilities of treatment as prevention.
Christian A. W. Bruhn (2011)
10.1016/j.lfs.2010.10.002
Substance use and HIV disease progression in the HAART era: implications for the primary prevention of HIV.
A. Carrico (2011)
10.1016/S0140-6736(11)61118-5
HPTN 052 and the future of HIV treatment and prevention
Andy Seale (2011)
10.2105/AJPH.2010.300059
MAYER AND VENKATESH RESPOND
K. Mayer (2011)
10.2471/BLT.09.067330
Preventing HIV transmission with antiretrovirals.
K. D. De Cock (2009)
10.1136/bmjqs-2011-000381
Using quality improvement to accelerate highly active antiretroviral treatment coverage in South Africa
Patty D Webster (2012)
10.1097/QAD.0b013e32833433fe
Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings
P. Dodd (2010)
10.1097/QAI.0b013e318202c82c
Who Gets Tested for HIV in a South African Urban Township? Implications for Test and Treat and Gender-Based Prevention Interventions
K. Venkatesh (2011)
10.1186/1471-2458-11-701
Sustainability of programs to reach high risk and marginalized populations living with HIV in resource limited settings: implications for HIV treatment and prevention
B. T. Montague (2011)
10.1377/hlthaff.28.6.1629
Investing to meet the scientific challenges of HIV/AIDS.
A. S. Fauci (2009)
10.1016/S0140-6736(11)60821-0
Treatment as prevention—a double hat-trick
J. Montaner (2011)
10.1093/cid/cir085
The Effect of Expanded Antiretroviral Treatment Strategies on the HIV Epidemic among Men Who Have Sex with Men in San Francisco
E. Charlebois (2011)
10.1186/1758-2652-14-28
HIV treatment for prevention
J. Ambrosioni (2011)
Test and treat for prevention of new HIV infections
D. V. D. Vijver (2010)
10.1097/COH.0b013e32833a6c32
Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update
R. Granich (2010)
10.1097/COH.0b013e32834fc1df
Interventions to improve the performance of HIV health systems for treatment-as-prevention in sub-Saharan Africa: the experimental evidence.
T. Bärnighausen (2012)
10.1097/QAD.0b013e3283402c3e
Remedicalizing an epidemic: from HIV treatment as prevention to HIV treatment is prevention.
Vinh-Kim Nguyen (2011)
10.1007/s12160-011-9271-3
Sexual HIV Transmission and Antiretroviral Therapy: A Prospective Cohort Study of Behavioral Risk Factors Among Men and Women Living with HIV/AIDS
S. Kalichman (2011)
10.1126/science.334.6063.1628
Breakthrough of the year. HIV treatment as prevention.
J. Cohen (2011)
10.1086/656810
HIV treatment as prevention and "the Swiss statement": in for a dime, in for a dollar?
M. Cohen (2010)
10.1146/ANNUREV.PUBLHEALTH.19.1.173
Review of community-based research: assessing partnership approaches to improve public health.
B. Israel (1998)
10.1097/COH.0b013e32834f5cf2
HIV treatment as prevention and HPTN 052.
M. Cohen (2012)
10.1097/QAD.0b013e328353b11b
Highly active antiretroviral therapy does not completely suppress HIV in semen of sexually active HIV-infected men who have sex with men
J. Politch (2012)
10.1097/QAD.0b013e32833f4b1b
Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis
G. Marks (2010)
10.1371/journal.pone.0010148
HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the “Test-and-Treat” Approach to Reduce HIV Transmission
V. Novitsky (2010)
10.1086/651478
Treatment to prevent transmission of HIV-1.
M. Cohen (2010)
10.2105/AJPH.2010.197608
Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission.
S. Kalichman (2011)
10.1097/COH.0b013e32834fcff6
Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.
A. Forsyth (2012)
10.1001/jama.2009.828
Universal voluntary testing and treatment for prevention of HIV transmission.
C. Dieffenbach (2009)
10.1093/cid/ciq243
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection.
E. Gardner (2011)
10.1086/381709
What makes clinical research in developing countries ethical? The benchmarks of ethical research.
E. Emanuel (2004)
10.1097/QAD.0b013e328345ef12
Trends in unsafe sex and influence of viral load among patients followed since primary HIV infection, 2000–2009
R. Seng (2011)
10.1016/S0140-6736(11)61117-3
HPTN 052 and the future of HIV treatment and prevention
Helen Epstein (2011)
10.1111/j.1468-1293.2009.00818.x
Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention
S. Kalichman (2010)
10.1111/J.1467-8519.2004.00412.X
The genesis of public health ethics.
Ronald Bayer (2004)
10.1093/cid/cir418
Expanding test and treat in correctional populations: a key opportunity to reduce racial disparities in HIV infection.
Amy C. Nunn (2011)
10.1097/QAI.0b013e3181f9c1f0
Expanded Highly Active Antiretroviral Therapy Coverage Among HIV-Positive Drug Users to Improve Individual and Public Health Outcomes
J. Montaner (2010)
10.1521/aeap.2011.23.5.393
Two sides to the HIV prevention coin: efficacy and effectiveness.
S. Kippax (2011)
10.1097/QAI.0b013e318236f7d2
Early Retention in HIV Care and Viral Load Suppression: Implications for a Test and Treat Approach to HIV Prevention
M. Mugavero (2012)
10.1097/COH.0b013e32833a6b11
Antiretroviral treatment of primary HIV infection to reduce onward transmission
E. Hamlyn (2010)
10.1097/QAD.0b013e32834e1592
Elimination of HIV by test and treat: a phantom of wishful thinking?
M. Kretzschmar (2012)
10.1097/COH.0b013e32833a51b2
Modelling sexual transmission of HIV: testing the assumptions, validating the predictions
R. Baggaley (2010)
10.1007/S11673-009-9147-4
Increasing Knowledge of HIV Infection Status through Opt-Out Testing
H. Jaffe (2009)
10.1001/archinternmed.2010.249
Comparative effectiveness of HIV testing and treatment in highly endemic regions.
E. Bendavid (2010)
10.1097/QAD.0b013e328340871d
Evidence is still required for treatment as prevention for riskier routes of HIV transmission.
D. Wilson (2010)
10.2174/157016211798038533
Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV
B. Williams (2011)
10.1097/COH.0b013e32834f3f13
Preventing HIV transmission through antiretroviral treatment-mediated virologic suppression: aspects of an emerging scientific agenda.
C. Dieffenbach (2012)
10.1186/1758-2652-14-S1-S1
Facing up to programmatic challenges created by the HIV/AIDS epidemic in sub-Saharan Africa
S. Heidari (2011)
10.1016/S0140-6736(06)69162-9
The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic
J. Montaner (2006)
10.1016/S1473-3099(11)70060-3
Community-based intervention to increase HIV testing and case detection in people aged 16-32 years in Tanzania, Zimbabwe, and Thailand (NIMH Project Accept, HPTN 043): a randomised study.
M. Sweat (2011)
10.1093/cid/ciq254
"Test and treat": is it enough?
J. Lange (2011)
10.1097/QAD.0b013e3283463f09
Psychiatric correlates of HAART utilization and viral load among HIV-positive impoverished persons
A. Carrico (2011)
10.1371/journal.pone.0011068
Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco
Moupali Das (2010)
10.1016/S0277-9536(02)00304-0
HIV and AIDS-related stigma and discrimination: a conceptual framework and implications for action.
R. Parker (2003)
10.2174/157016211798038515
Universal Testing and Treatment as an HIV Prevention Strategy: Research Questions and Methods
R. Hayes (2011)
10.1056/NEJMoa1105243
Prevention of HIV-1 infection with early antiretroviral therapy.
M. Cohen (2011)
10.1111/j.1742-1241.2010.02381.x
Potential and limitations of a ‘test and treat’ strategy as HIV prevention in the United States
D. Holtgrave (2010)
10.1016/S0140-6736(11)60896-9
Test and treat in HIV: success could depend on rapid detection
T. Cohen (2011)
10.1057/jphp.2010.29
Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: Has WHO offered a milestone for HIV prevention?
S. Menon (2010)
10.7326/0003-4819-156-11-201206050-00419
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel
M. Thompson (2012)
10.1086/655889
Rethinking prevention of HIV type 1 infection.
D. Burns (2010)
10.1097/COH.0b013e3283504ab7
Treatment as prevention: translating efficacy trial results to population effectiveness.
G. Garnett (2012)
10.1016/S0140-6736(10)60416-3
A tale of two-component generalised HIV epidemics
J. Shelton (2010)
10.1016/S0140-6736(09)62064-X
New WHO HIV treatment and prevention guidelines
S. Crowley (2010)
10.1097/01.aids.0000327438.13291.62
Stigma in the HIV/AIDS epidemic: a review of the literature and recommendations for the way forward
A. Mahajan (2008)
10.1097/QAD.0B013E328340073A
Reply to 'Evidence is still required for treatment as prevention for riskier routes of HIV transmission'
K. Johnston (2010)
10.1177/1545109711418120
The Achilles’ Heel of HIV Treatment for Prevention
S. Kalichman (2011)
10.1097/COH.0b013e32834fcf6b
Treatment-for-prevention: clinical considerations.
S. Lockman (2012)
10.1371/journal.pone.0031859
Recent HIV-1 Infection: Identification of Individuals with High Viral Load Setpoint in a Voluntary Counselling and Testing Centre in Rural Mozambique
C. Serna-Bolea (2012)
10.1097/COH.0b013e32834f9927
HIV treatment as prevention among injection drug users.
E. Wood (2012)
10.1097/QAD.0b013e328352ae09
Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002–2011 survey
S. Lambert-Niclot (2012)
10.1086/655130
Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC.
R. Walensky (2010)
10.2105/AJPH.2011.300594
Beyond the distinction between biomedical and social dimensions of HIV prevention through the lens of a social public health.
S. Kippax (2012)
10.1086/648729
Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.
V. Gill (2010)
10.1097/COH.0b013e3283506613
Testing for acute HIV infection: implications for treatment as prevention.
S. Owen (2012)
10.2174/157016211798038560
Acknowledgements and Editorial (Exploring the Role of “Treatment as Prevention”)
M. Harris (2011)
10.1089/apc.2009.0309
Adherence to antiretroviral therapy and HIV transmission risks: implications for test-and-treat approaches to HIV prevention.
S. Kalichman (2010)
10.1377/hlthaff.28.6.1666
Ethical challenges in long-term funding for HIV/AIDS.
D. Brock (2009)
10.1097/QAI.0b013e3181fbca5a
Progress in HIV Reduction and Prevention Among Injection and Noninjection Drug Users
N. Crawford (2010)
Biomedical Approaches to HIV Prevention
K. Mayer (2010)
10.1089/apc.2010.0198
Letter to the Editor: Treatment as prevention: are HIV clinic patients interested in starting antiretroviral therapy to decrease HIV transmission?
J. Dombrowski (2010)
10.4102/SAJHIVMED.V12I3.178
When to start antiretroviral therapy in adults : the results of HPTN 052 move us closer to a 'test-and-treat' policy : opinion
N. Geffen (2011)
10.1071/SH10084
Treatment for prevention of HIV transmission in a localised epidemic: the case for South Australia.
Kelly-Jean Heymer (2011)
10.1001/archinternmed.2010.248
"A bird in the hand...": a commentary on the test and treat approach for HIV.
E. Charlebois (2010)
10.1371/journal.pone.0015510
Transmitted Drug Resistance in Persons with Acute/Early HIV-1 in San Francisco, 2002-2009
V. Jain (2010)
10.1097/QAI.0b013e3181f0cbf3
HIV treatment as prevention: to be or not to be?
M. Cohen (2010)
10.1007/s10461-012-0186-1
Behavioral Factors in Assessing Impact of HIV Treatment as Prevention
D. Holtgrave (2012)
10.1371/journal.pone.0010981
Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia
A. Hoare (2010)
10.1097/QAD.0b013e3283366782
Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy?
B. Wagner (2010)



This paper is referenced by
Characterisation of Lentiviral Vpr Function and Mechanism
CR Van Tulleken (2017)
10.1177/0956462420927205
Antiretroviral therapy adherence among patients enrolled after the initiation of the Universal Test and Treat strategy in Dessie town: a cross-sectional study
Yitayish Damtie (2020)
10.1186/1472-6939-15-54
A scoping study to identify opportunities to advance the ethical implementation and scale-up of HIV treatment as prevention: priorities for empirical research
R. Knight (2014)
10.2105/AJPH.2015.302905
Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review.
A. Aidala (2016)
10.1038/cti.2015.23
Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses
S. Eid (2015)
Objective In view of expanding ‘test and treat’ initiatives, we sought to elicit how the experience of HIV testing influenced subsequent engagement in HIV care among people diagnosed with HIV
Alison Wringe (2017)
10.1097/QAI.0000000000001338
Capturing HIV Incidence Among MSM Through At-Home and Self-reported Facility-based Testing
E. Hall (2017)
10.1007/s10461-014-0959-9
Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy
C. Newman (2014)
10.1089/lgbt.2014.0086
Ensuring the Ethical Implementation of the New World Health Organization Pre-Exposure Prophylaxis Recommendations for Men Who Have Sex with Men.
K. S. Arora (2015)
10.2105/AJPH.2014.302531
Self-implemented HIV testing: perspectives on improving dissemination among urban African American youths.
J. Catania (2015)
Resistencia genética a la infección por VIH-1 mediada por polimorfismos genéticos del CR2
Facultad de Ciencias Experimentales (2014)
10.1136/bmjopen-2019-030228
Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study
D. Onoya (2020)
10.1177/0969733017693442
Ethically providing Routine HIV testing services to bereaved populations
B. Burmen (2019)
10.1007/s11904-016-0307-y
HIV Self-Testing: a Review of Current Implementation and Fidelity
Kristecia S Estem (2016)
10.1111/1552-6909.12481
A multilevel understanding of HIV/AIDS disease burden among African American women.
B. Brawner (2014)
Access to Healthcare by Pregnant and Lactating Women Living with HIV and AIDS in Kenya
A. Gayapersad (2016)
10.1016/j.evalprogplan.2020.101859
The development of Maisha, a video-assisted counseling intervention to address HIV stigma at entry into antenatal care in Tanzania.
M. Watt (2020)
Renju, J (2017) HIV testing experiences and their implications for patient engagement with HIV care and treatment on the eve of ’test and treat’: findings from a multicoun-
A. Wringe (2018)
10.1002/jia2.25455
What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
D. Havlir (2020)
10.1111/hiv.12750
Population uptake and effectiveness of test‐and‐treat antiretroviral therapy guidelines for preventing the global spread of HIV: an ecological cross‐national analysis
A. Mendez-Lopez (2019)
10.1007/s10461-015-1109-8
Economic Evaluation of Community-Based HIV Prevention Programs in Ontario: Evidence of Effectiveness in Reducing HIV Infections and Health Care Costs
Stephanie K. Y. Choi (2015)
10.1007/82_2015_440
HIV therapy-the state of art.
D. Looney (2015)
10.1007/s10461-019-02711-5
Oral HIV Self-Implemented Testing: Performance Fidelity Among African American MSM
J. Catania (2019)
10.1097/QAD.0000000000001416
Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa
N. Croome (2017)
10.1097/QAI.0000000000001410
Preferences for Home-Based HIV Testing Among Heterosexuals at Increased Risk for HIV/AIDS: New Orleans, Louisiana, 2013
W. Robinson (2017)
10.1136/sextrans-2016-052969
HIV testing experiences and their implications for patient engagement with HIV care and treatment on the eve of ‘test and treat’: findings from a multicountry qualitative study
A. Wringe (2017)
10.1007/s13142-015-0331-2
Bridging barriers to clinic-based HIV testing with new technology: translating self-implemented testing for African American youth
J. Catania (2015)
10.1093/trstmh/trt105
Strengthening the HIV cascade to ensure an effective future ART response in sub-Saharan Africa.
D. Govindasamy (2014)
10.2105/AJPH.2015.302970
Trauma-Informed Social Policy: A Conceptual Framework for Policy Analysis and Advocacy.
Elizabeth A Bowen (2016)
10.1089/lgbt.2014.0114
Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.
Patrick D Herron (2016)
10.1186/s13690-020-00473-4
Same-day antiretroviral treatment (ART) initiation and associated factors among HIV positive people in Northwest Ethiopia: baseline characteristics of prospective cohort
Nurilign Abebe Moges (2020)
Semantic Scholar Logo Some data provided by SemanticScholar